HOME >> BIOLOGY >> NEWS
Yale technology spins out varicose vein device company: Vascular Insights, LLC

New Haven, Conn. -- A new company, Vascular Insights, LLC, was founded to develop, manufacture and market devices to treat varicose vein disease, based on technology invented by Michael Tal, M.D., assistant professor of diagnostic radiology and director of research interventional radiology at Yale University School of Medicine.

"While varicose vein disease is normally not a life threatening condition, it can cause severe leg discomfort and serious complications, including clotting, leg edema, skin ulceration and thrombophlebitis," said Tal. "However, a universal problem caused by the condition is unsightliness of the bulging veins."

Vascular Insights is developing a simplified procedure using a single, disposable product for elimination of varicose veins. Among the procedure's advantages, the company believes it will eliminate the need for anesthesia, hospitalization or surgery, and cause less damage to surrounding tissue and nerves. This would translate into considerably reduced convalescence, complications and pain for patients. Varicose veins, including sapheno-femoral reflux disease, affect between 75 and 150 million people in North America and Western Europe. The condition involves major blood vessels of the leg, and is different than "spider veins," which affects the minor blood vessels.

Traditional therapy for varicose veins is surgery, but worldwide only an estimated one million people undergo the extensive surgical stripping and ligation operations each year at a cost of as much as between $2,500 and $5,000 per leg.

"The simplicity of the Vascular Insights approach represents an attractive new treatment option for the present one million annual procedures and the 30 to 50 million varicose vein sufferers in the US who currently do not seek treatment," said John Marano,
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
5-Apr-2006


Page: 1 2

Related biology news :

1. AFCYBER holds science and technology symposium
2. New technology reveals seal behavior
3. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
4. FDA Nanotechnology Task Force takes positive step forward
5. Liverpool amongst first in UK to install unique DNA sequencing technology
6. EPA foregoes opportunity to improve nanotechnology oversight
7. The Cancer Genome Atlas awards funds for technology development
8. Autism theory put to the test with new technology
9. Nanotechnology, medicine and bioethics
10. Nanotechnology: consumers must be convinced benefits outweigh risks
11. Stem cell licensing deal positions Toronto as world leader in technology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... ... November 12, 2019 , ... ... global leader in the design and manufacturer of technical ergonomic seating solutions, ... adjustable footrests compliant with Healthier Hospital Initiative guidelines. Established by Practice Greenhealth, ...
(Date:11/11/2019)... ORLANDO, Fla. (PRWEB) , ... November 11, 2019 ... ... DNA Sequencing (NGS) in microbial identification, played a key role in the award-winning ... Investigation” led by the Rothman Institute. The molecular diagnostic laboratory processed samples using ...
(Date:11/6/2019)... ... November 06, 2019 , ... NDA Partners Chairman Carl ... executive with expertise in clinical pharmacology and pharmacometrics and a widely recognized expert ... has joined the firm as an Expert Consultant. , Dr. Stanski has served ...
Breaking Biology News(10 mins):
(Date:10/26/2019)... ... October 24, 2019 , ... Sparks Marketing Group, Inc. ... (BMMG), a boutique healthcare-specific marketing firm, to strengthen the agency’s growing focus on ... , Healthcare clients in pharma, bio-therapeutics, medical device and healthcare technologies currently account ...
(Date:10/22/2019)... ... , ... DermBiont, a clinical stage microbiome biotechnology company developing ... safety endpoints, with no application site reactions and no adverse events, in a ... tinea pedis (athlete’s foot). Additionally, the trial demonstrated a clinical response with improvement ...
(Date:10/10/2019)... ... October 09, 2019 , ... The ... Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for the 2019 ... Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... Project (TMP), Madhumita Suresh and Leslie Maurer presented company executives with a set ... and Science (MBS) graduates will offer insights from their TMP to a wider ...
Breaking Biology Technology:
Cached News: